Prof. Dr. med. Peter Fasching



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

SNP-SNP interaction analysis of NF-?B signaling pathway on breast cancer survival (2015) Jamshidi M, Fagerholm R, Khan S, Aittomaki K, Czene K, Darabi H, Li J, et al. Journal article The integrative epigenomic-transcriptomic landscape of ER positive breast cancer (2015) Gao Y, Jones A, Fasching P, Rübner M, Beckmann M, Widschwendter M, Teschendorff AE Journal article Zukunft mammographie-basierter Bildgebung [Future of mammography-based imaging] (2014) Schulz-Wendtland R, Wittenberg T, Michel T, Hartmann A, Beckmann M, Rauh C, Judt S, et al. Journal article, Original article Fully automated nipple detection in 3D breast ultrasound images (2014) Wang L, Böhler T, Zöhrer F, Georgii J, Rauh C, Fasching P, Brehm B, et al. Conference contribution Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome (2014) Charbonneau B, Moysich KB, Kalli KR, Oberg AL, Vierkant RA, Fogarty ZC, Block MS, et al. Journal article Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)+ (2014) Von Minckwitz G, Loibl S, Untch M, Eidtmann H, Rezai M, Fasching P, Tesch H, et al. Journal article Time and Resources Needed to Document Patients with Breast Cancer from Primary Diagnosis to Follow-up - Results of a Single-center Study (2014) Lux MP, Sell CS, Fasching P, Seidl-Ertel J, Bani M, Schrauder MG, Jud S, et al. Journal article Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study (2014) Fasching P, Fehm T, Kellner S, De Waal J, Rezal M, Baler B, Baake G, et al. Journal article FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients (2014) Fasching P, Jud S, Hauschild M, Kuemmel S, Schuette M, Warm M, Hanf V, et al. Journal article Variation in NF-?B signaling pathways and survival in invasive epithelial ovarian cancer (2014) Block MS, Charbonneau B, Vierkant RA, Fogarty Z, Bamlet WR, Pharoah PDP, Chenevix-Trench G, et al. Journal article